Rosenson RS - Search Results

1

Role of the endocannabinoid system in abdominal obesity and the implications for cardiovascular risk.

Rosenson RS. Rosenson RS. Cardiology. 2009;114(3):212-25. doi: 10.1159/000230691. Epub 2009 Jul 29. Cardiology. 2009. PMID: 19641317 Review.

2

Statin-induced lowering of LDL cholesterol associated with a reduced risk for cardiovascular events, not likely outweighed by the risk of diabetes, for people at low short-term risk of cardiovascular disease.

Rosenson RS. Rosenson RS. Evid Based Med. 2013 Aug;18(4):142-3. doi: 10.1136/eb-2012-101028. Epub 2012 Nov 2. Evid Based Med. 2013. PMID: 23125231 No abstract available.

3

Refining Lipoprotein(a) Associated Cardiovascular Risk in Women.

Rosenson RS, Marcovina SM. Rosenson RS, et al. J Am Coll Cardiol. 2018 Jul 17;72(3):297-299. doi: 10.1016/j.jacc.2018.05.011. Epub 2018 Jul 9. J Am Coll Cardiol. 2018. PMID: 30012323 No abstract available.

4

How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD.

Hong KN, Fuster V, Rosenson RS, Rosendorff C, Bhatt DL. Hong KN, et al. Among authors: rosenson rs. J Am Coll Cardiol. 2017 Oct 24;70(17):2171-2185. doi: 10.1016/j.jacc.2017.09.001. J Am Coll Cardiol. 2017. PMID: 29050566 Review.

5

Integrated Measure for Atherogenic Lipoproteins in the Modern Era: Risk Assessment Based on Apolipoprotein B.

Rosenson RS, Hegele RA, Gotto AM Jr. Rosenson RS, et al. J Am Coll Cardiol. 2016 Jan 19;67(2):202-204. doi: 10.1016/j.jacc.2015.10.059. J Am Coll Cardiol. 2016. PMID: 26791068 No abstract available.

6

Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.

Rosenson RS, Kent ST, Brown TM, Farkouh ME, Levitan EB, Yun H, Sharma P, Safford MM, Kilgore M, Muntner P, Bittner V. Rosenson RS, et al. J Am Coll Cardiol. 2015 Jan 27;65(3):270-7. doi: 10.1016/j.jacc.2014.09.088. J Am Coll Cardiol. 2015. PMID: 25614424

7

Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients.

Rosenson RS, Hislop C, Elliott M, Stasiv Y, Goulder M, Waters D. Rosenson RS, et al. J Am Coll Cardiol. 2010 Sep 28;56(14):1079-88. doi: 10.1016/j.jacc.2010.06.015. J Am Coll Cardiol. 2010. PMID: 20863951 Clinical Trial.

8

Aspirin for primary prevention of cardiovascular events in people with diabetes.

Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS; American Diabetes Association; American Heart Association; American College of Cardiology Foundation. Pignone M, et al. Among authors: rosenson rs. J Am Coll Cardiol. 2010 Jun 22;55(25):2878-86. doi: 10.1016/j.jacc.2010.04.003. J Am Coll Cardiol. 2010. PMID: 20579547 Review. No abstract available.

9

Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.

Rosenson RS, Davidson MH, Hirsh BJ, Kathiresan S, Gaudet D. Rosenson RS, et al. J Am Coll Cardiol. 2014 Dec 16;64(23):2525-40. doi: 10.1016/j.jacc.2014.09.042. J Am Coll Cardiol. 2014. PMID: 25500239 Review.

10

Effects of peroxisome proliferator-activated receptors on lipoprotein metabolism and glucose control in type 2 diabetes mellitus.

Rosenson RS. Rosenson RS. Am J Cardiol. 2007 Feb 19;99(4A):96B-104B. doi: 10.1016/j.amjcard.2006.11.010. Epub 2006 Dec 22. Am J Cardiol. 2007. PMID: 17307062 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results